BANK VONTOBEL/CALL/CVS HEALTH/72/0.1/20.12.24 Share Price

Warrant

DE000VD3YGA0

Market Closed - Boerse Frankfurt Warrants 18:53:54 02/07/2024 BST
0.102 EUR -7.27% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/72/0.1/20.12.24
Current month-15.70%
1 month-21.54%
Date Price Change
02/07/24 0.102 -7.27%
01/07/24 0.11 -9.09%
28/06/24 0.121 +19.80%
27/06/24 0.101 -30.82%
26/06/24 0.146 -3.95%

Real-time Boerse Frankfurt Warrants

Last update July 02, 2024 at 06:53 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD3YGA
ISINDE000VD3YGA0
Date issued 11/04/2024
Strike 72 $
Maturity 20/12/2024 (171 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.6
Lowest since issue 0.057
Spread 0.01
Spread %9.17%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
57.52 USD
Average target price
69.1 USD
Spread / Average Target
+20.12%
Consensus